1995
DOI: 10.1253/jcj.59.624
|View full text |Cite
|
Sign up to set email alerts
|

Comparable Effects of Angiotensin II and Converting Enzyme Blockade on Hemodynamics and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 20 publications
1
5
0
Order By: Relevance
“…Other studies have clearly shown in SHRs that myocardial fibrosis is decreased by ACE inhibitors, such as lisinopril [32], enalapril [25] and trandolapril [37] and by angiotensin II AT 1 receptor antagonists such as losartan and candesartan [16,38]. Our data showed that the TVCC was similarly reduced by ACE inhibition and angiotensin II AT 1 receptor antagonism and this decrease was independent from the resulting decreased MAPs (R = 0.190; P = 0.115, N.S.).…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…Other studies have clearly shown in SHRs that myocardial fibrosis is decreased by ACE inhibitors, such as lisinopril [32], enalapril [25] and trandolapril [37] and by angiotensin II AT 1 receptor antagonists such as losartan and candesartan [16,38]. Our data showed that the TVCC was similarly reduced by ACE inhibition and angiotensin II AT 1 receptor antagonism and this decrease was independent from the resulting decreased MAPs (R = 0.190; P = 0.115, N.S.).…”
Section: Discussionsupporting
confidence: 75%
“…Linz et al [31] have reported that ramipril, at a dose that did not decrease blood pressure, reversed LVH in aortic-banded rats. Moreover, Mori et al [32] have observed that short-term treatment with lisinopril 3 mg/kg/day for 2 weeks inhibited the progression of hypertension and suppressed the development of LVH in SHRs, whereas treatment with lisinopril 0.5 mg/kg/day for 2 weeks suppressed the development of LVH without reducing blood pressure. Nevertheless, it certainly remains that the prevention of myocardial cell hypertrophy and therefore the regression of LVH depend, at least in part, on afterload reduction.…”
Section: Discussionmentioning
confidence: 99%
“…Our results are in agreement with those of Linz et al (1995) who have reported that ramipril, at a dose that did not decrease blood pressure, reversed LVH in aortic-banded rats. Moreover, Mori et al (1995) have observed that short-term treatment with lisinopril, 3 mg·kg -1 per day for 2 weeks, inhibited the progression of hypertension and suppressed the development of LVH in SHR, whereas 0.5 mg·kg -1 ·day -1 of lisinopril suppressed the development of LVH without reducing blood pressure. In order to clarify this point, the correlations between tissue ACE activities, blood pressure and cardiac hypertrophy were analysed by Takai et al (2004), using several ACE inhibitors.…”
Section: Discussionmentioning
confidence: 99%
“…(1995) who have reported that ramipril, at a dose that did not decrease blood pressure, reversed LVH in aortic‐banded rats. Moreover, Mori et al. (1995) have observed that short‐term treatment with lisinopril, 3 mg·kg −1 per day for 2 weeks, inhibited the progression of hypertension and suppressed the development of LVH in SHR, whereas 0.5 mg·kg −1 ·day −1 of lisinopril suppressed the development of LVH without reducing blood pressure.…”
Section: Discussionmentioning
confidence: 99%
“…However, the present findings can not be extrapolated directly to clinical hypertension, despite SHR being an excellent model of human hypertension. 9,10 …”
Section: Study Limitationsmentioning
confidence: 99%